Ind-Swift Ltd.

21.35 -0.85 ▼-3.8%

19 April 2024, 12:53:49 PM
Volume: 56,829

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.indswift.com
Market Cap 115.48 Cr.
Enterprise Value(EV) 1,097.30 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 5.50 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 3.88 Trailing Twelve Months Ending 2023-12
Industry PE 41.01 Trailing Twelve Months Ending 2023-12
Book Value / Share -134.41 Trailing Twelve Months Ending 2023-12
Price to Book Value -0.16 Calculated using Price: 21.32
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 5.42 Cr. 54,164,653 Shares
FaceValue 2
About Ind-Swift Ltd.
Ind-Swift Limited was incorporated as a public limited company on June 6, 1986 under the Companies Act 1956.It is the flagship company of India based Ind Swift Group. Ind-Swift Limited is a north India based pharmaceutical company.

Ind-Swift Ltd. Delivery

Delivered Qty
Traded Qty

Ind-Swift Ltd. Performance

1 Day
-3.83%
1 Week
-20.48%
1 Month
+10.05%
3 Month
+18.28%
6 Month
+37.74%
1 Year
+141.24%
2 Year
+80.17%
5 Year
+306.67%
10 Year
+216.30%

Ind-Swift Ltd. Fundamental Ratios

5 years 2016-03 2017-03 2018-03 2022-03 2023-03
Return on Equity (%) 0 0 0 0 0
Return on Capital Employed (%) -22.84 -56.7 -10.34 10.83 28.45
Return on Assets (%) -18.95 -42.37 -8.46 -3.21 4.07

Ind-Swift Ltd. Balance Sheet

Particulars 6 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds -245 -616 -663 -720 -705 -713
Non Curr. Liab. 679 672 680 634 418 424
Curr. Liab. 621 608 598 718 936 928
Minority Int.
Equity & Liab. 1,055 665 615 632 649 639
Non Curr. Assets 433 458 429 389 376 373
Curr. Assets 612 206 186 242 273 266
Misc. Exp. not W/O 10
Total Assets 1,055 665 615 632 649 639

Ind-Swift Ltd. Profit and Loss

Particulars 6 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 304 263 270 398 411 473
Other Income 13 14 15 24 12 18
Total Income 317 277 284 421 423 491
Total Expenditure -461 -328 -264 -352 -369 -431
PBIDT -144 -52 21 69 54 60
Interest -19 -16 -11 -57 -60 -63
Depreciation -36 -36 -35 -32 -29 -27
Taxation 0 -1 -1 0
Exceptional Items -260 -28 1 61 61
PAT -200 -364 -54 -20 26 30
Minority Interest
Share Associate -14 -8 4
Other Related Items
Consolidated Net Profit -214 -373 -50 -20 26 30
Adjusted EPS -42 -69 -9 -4 5 6

Ind-Swift Ltd. Cash Flow

Particulars 5 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -119 -2 7 50 73
Cash Fr. Inv. 10 4 -6 -18 -29
Cash Fr. Finan. 110 -11 -6 -45 -47
Net Change 0 -8 -5 -13 -3
Cash & Cash Eqvt 17 9 4 16 13

Ind-Swift Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 55.55 55.58 55.58 55.58 55.58 55.58 55.58 55.58 55.58
Public 44.45 44.42 44.42 44.42 44.42 44.42 44.42 44.42 44.42
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 73.46 73.43 42.81 42.81 42.81 42.81 42.81 42.81 42.81
No. of Shareholders (in Lacs)

Ind-Swift Ltd. Announcements

Wed, 10 Apr 2024
Updates
Ind-Swift Limited has informed the Exchange regarding 'Update on Merger of the company with M/s Ind Swift Laboratories Limited (Group Company)'.
Tue, 09 Apr 2024
Price movement
Significant movement in price has been observed in Ind-Swift Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Sat, 06 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Ind-Swift Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Ind-Swift Ltd. Technical Scans

Thu, 18 Apr 2024
Opening at Low Opening at Low
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days
Making Lower Lows for 3 days Making Lower Lows for 3 days
Closing Below Previous Low for 2 Days Closing Below Previous Low for 2 Days

Ind-Swift Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,015.10 1,510.20 -0.4%
Cipla Ltd. 108,808.58 1,350.85 +0.3%
Dr. Reddy's Laboratories Ltd. 99,408.67 5,908.00 -0.8%
Divi's Laboratories Ltd. 98,683.96 3,700.00 -0.2%
Mankind Pharma Ltd. 96,037.07 2,349.95 -1.9%
Zydus Lifesciences Ltd. 94,213.69 919.80 -1.8%
Apollo Hospitals Enterprise Ltd. 87,250.69 6,147.75 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.87 1,510.20 -0.4%
Cipla Ltd. Consolidated 2023-12 29.34 1,350.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.01 5,908.00 -0.8%
Divi's Laboratories Ltd. Consolidated 2023-12 71.36 3,700.00 -0.2%
Mankind Pharma Ltd. Consolidated 2023-12 55.61 2,349.95 -1.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.68 919.80 -1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 110.54 6,147.75 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.83 1,510.20 -0.4%
Cipla Ltd. Consolidated 2023-12 4.20 1,350.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,908.00 -0.8%
Divi's Laboratories Ltd. Consolidated 2023-12 7.57 3,700.00 -0.2%
Mankind Pharma Ltd. Consolidated 2023-12 10.81 2,349.95 -1.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.00 919.80 -1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.92 6,147.75 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,510.20 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,350.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,908.00 -0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,700.00 -0.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,349.95 -1.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 919.80 -1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,147.75 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,510.20 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,350.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,908.00 -0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,700.00 -0.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,349.95 -1.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 919.80 -1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,147.75 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,510.20 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,350.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,908.00 -0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,700.00 -0.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,349.95 -1.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 919.80 -1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,147.75 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,510.20 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,350.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,908.00 -0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,700.00 -0.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,349.95 -1.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 919.80 -1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,147.75 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,510.20 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,350.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,908.00 -0.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,700.00 -0.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,349.95 -1.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 919.80 -1.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,147.75 +1.2%

Ind-Swift Ltd. FAQ's

What is Ind-Swift share price?

Can I buy Ind-Swift shares now?

What is the Market Cap of Ind-Swift?

What are the key metrics to analyse Ind-Swift?

What is the 52 Week High and Low of Ind-Swift?

What is the trend of Ind-Swift share price?